ISO 15189 is the international standard that specifies requirements for quality and competence in medical laboratories, established by the International Organization for Standardization. Its core objective is to deliver accurate, timely, and reliable laboratory results that enhance patient care and foster confidence in diagnostic services. It is applicable to medical laboratories in developing their management systems and assessing their competence, and it is also applicable for confirming or recognizing the competence of medical laboratories by laboratory users, regulatory authorities and accreditation bodies.
The standard was initially introduced in 2003 by ISO, developed collaboratively by Technical Committee ISO slash TC 212 and CEN slash TC 140, and it underwent its fourth revision in 2022. Although ISO 15189 focuses on laboratory testing, such as blood banks, immunology, and microbiology laboratories, it can also be applied to other diagnostic services, including imaging and respiratory therapy.
The most significant update in the standard's history came in December 2022, following user feedback gathered from a 2017 survey. That survey indicated that many lab personnel found the existing standard difficult to interpret and implement, while new technological and medical developments had since emerged following the previous 2012 release. This critical update now aligns the standard with the principles of a number of areas, namely the application of risk management, safety in the work environment, the collection and transport of patient samples, point-of-care testing, and the exchange of information between laboratories.
Structurally, the 2022 edition represents a deliberate convergence with other major quality standards. This edition aligns structurally with ISO slash IEC 17025 colon 2017 and incorporates the requirements of the ISO 22870 standard to offer a fully integrated approach to point-of-care testing. Beyond that, ISO 15189 builds upon the foundational principles of ISO 9001, which sets generic quality management requirements applicable across industries, and it also incorporates and adapts the technical competence requirements of ISO slash IEC 17025.
One notable shift in the 2022 revision concerns documentation flexibility. ISO 15189 colon 2022 states that the management system documents can, but are not required to, be contained in a quality manual, whereas ISO 15189 colon 2012 maintained that the laboratory shall establish and maintain a quality manual. More broadly, the objective of the revised standard is to promote the welfare of patients and satisfaction of laboratory users through confidence in the quality and competence of medical laboratories, and it contains requirements for the medical laboratory to plan and implement actions to address risks and opportunities for improvement.
Among its detailed provisions, the standard requires laboratories to establish and document procedures to avoid conflicts of interest and protect patient information, reflecting its emphasis on impartiality and confidentiality as core operating principles.
In the UK, ISO 15189 underpins the entire national system of pathology laboratory accreditation, administered by the United Kingdom Accreditation Service, UKAS. This relationship is not merely advisory. Although there is no single statute that names ISO 15189 as a legal requirement, in practice UKAS accreditation to ISO 15189 colon 2022 is the expected standard for NHS pathology services and is required by commissioners, screening programmes and many service-level agreements. This means that, in effect, NHS trusts across the country cannot function as recognised pathology providers without maintaining this accreditation, even though no single law compels it directly.
The mechanics of UK accreditation are granular rather than blanket. Due to the nature of the way in which UKAS grants accreditation, it is the test that is accredited and not the laboratory, meaning UKAS maintains a register of laboratories accredited to ISO 15189 colon 2022 that can be accessed via the UKAS website, with a schedule of accreditation listing the individual tests for which each laboratory is currently accredited. As a result, pathology reports may contain a combination of accredited and unaccredited tests, without this necessarily indicating any difference in quality.
Assessment against the standard is continuous rather than one-off. At NHS trusts such as Newcastle Hospitals, compliance with the ISO 15189 standard is assessed by UKAS on at least an annual basis, with conformance to these standards and ongoing accreditation remaining the prime quality objective for laboratory services. When non-conformities are identified during these assessments, the expected response is systemic rather than superficial: most laboratories pass assessment when they treat findings as opportunities to strengthen the system, apply genuine root cause analysis, and provide clear, dated, traceable evidence that the action has been embedded.
Some NHS trusts, including Barnsley Hospital, still operate under the earlier ISO 15189 colon 2012 standard, reflecting a transition period across the UK health system as laboratories migrate their accreditation to the 2022 edition. This staggered adoption is typical of large-scale standard revisions across a national network of hundreds of laboratories, each needing to be individually reassessed against the new requirements.
Ultimately, ISO 15189 functions in the UK not as an optional quality mark but as the practical backbone of trust in diagnostic medicine. It gives patients, clinicians, commissioners and screening programmes a consistent, internationally recognised assurance that a blood test, biopsy result or microbiology culture has been produced by a laboratory operating under rigorously and independently verified standards of competence, traceability and safety.
The standard was initially introduced in 2003 by ISO, developed collaboratively by Technical Committee ISO slash TC 212 and CEN slash TC 140, and it underwent its fourth revision in 2022. Although ISO 15189 focuses on laboratory testing, such as blood banks, immunology, and microbiology laboratories, it can also be applied to other diagnostic services, including imaging and respiratory therapy.
The most significant update in the standard's history came in December 2022, following user feedback gathered from a 2017 survey. That survey indicated that many lab personnel found the existing standard difficult to interpret and implement, while new technological and medical developments had since emerged following the previous 2012 release. This critical update now aligns the standard with the principles of a number of areas, namely the application of risk management, safety in the work environment, the collection and transport of patient samples, point-of-care testing, and the exchange of information between laboratories.
Structurally, the 2022 edition represents a deliberate convergence with other major quality standards. This edition aligns structurally with ISO slash IEC 17025 colon 2017 and incorporates the requirements of the ISO 22870 standard to offer a fully integrated approach to point-of-care testing. Beyond that, ISO 15189 builds upon the foundational principles of ISO 9001, which sets generic quality management requirements applicable across industries, and it also incorporates and adapts the technical competence requirements of ISO slash IEC 17025.
One notable shift in the 2022 revision concerns documentation flexibility. ISO 15189 colon 2022 states that the management system documents can, but are not required to, be contained in a quality manual, whereas ISO 15189 colon 2012 maintained that the laboratory shall establish and maintain a quality manual. More broadly, the objective of the revised standard is to promote the welfare of patients and satisfaction of laboratory users through confidence in the quality and competence of medical laboratories, and it contains requirements for the medical laboratory to plan and implement actions to address risks and opportunities for improvement.
Among its detailed provisions, the standard requires laboratories to establish and document procedures to avoid conflicts of interest and protect patient information, reflecting its emphasis on impartiality and confidentiality as core operating principles.
In the UK, ISO 15189 underpins the entire national system of pathology laboratory accreditation, administered by the United Kingdom Accreditation Service, UKAS. This relationship is not merely advisory. Although there is no single statute that names ISO 15189 as a legal requirement, in practice UKAS accreditation to ISO 15189 colon 2022 is the expected standard for NHS pathology services and is required by commissioners, screening programmes and many service-level agreements. This means that, in effect, NHS trusts across the country cannot function as recognised pathology providers without maintaining this accreditation, even though no single law compels it directly.
The mechanics of UK accreditation are granular rather than blanket. Due to the nature of the way in which UKAS grants accreditation, it is the test that is accredited and not the laboratory, meaning UKAS maintains a register of laboratories accredited to ISO 15189 colon 2022 that can be accessed via the UKAS website, with a schedule of accreditation listing the individual tests for which each laboratory is currently accredited. As a result, pathology reports may contain a combination of accredited and unaccredited tests, without this necessarily indicating any difference in quality.
Assessment against the standard is continuous rather than one-off. At NHS trusts such as Newcastle Hospitals, compliance with the ISO 15189 standard is assessed by UKAS on at least an annual basis, with conformance to these standards and ongoing accreditation remaining the prime quality objective for laboratory services. When non-conformities are identified during these assessments, the expected response is systemic rather than superficial: most laboratories pass assessment when they treat findings as opportunities to strengthen the system, apply genuine root cause analysis, and provide clear, dated, traceable evidence that the action has been embedded.
Some NHS trusts, including Barnsley Hospital, still operate under the earlier ISO 15189 colon 2012 standard, reflecting a transition period across the UK health system as laboratories migrate their accreditation to the 2022 edition. This staggered adoption is typical of large-scale standard revisions across a national network of hundreds of laboratories, each needing to be individually reassessed against the new requirements.
Ultimately, ISO 15189 functions in the UK not as an optional quality mark but as the practical backbone of trust in diagnostic medicine. It gives patients, clinicians, commissioners and screening programmes a consistent, internationally recognised assurance that a blood test, biopsy result or microbiology culture has been produced by a laboratory operating under rigorously and independently verified standards of competence, traceability and safety.
